BUFFALO, N.Y. — Among the many differences between girls and boys, add the effects from caffeine — physiological, behavioral and subjective — to the list.
Results of a double-blind, placebo-controlled, dose-response study of the response of yout…
Large doses of a bone anabolic hormone called parathyroid hormone-related protein, PTHrP, increases spine bone mineral density in post-menopausal women by almost five percent in only three months, according to a study at the University of Pittsburgh School of Medicine.
A study conducted on 404 patients at several U.S. sites has determined that a new drug called Rasagiline effectively treats early-stage Parkinson’s disease. The study was reported in the December Archives of Neurology. “These findings are especially important since hopes for treating Parkinson’s with fetal cells were recently dashed,” said Technion-Israel Institute of Technology Professor Moussa Youdim, who developed Rasagiline with Prof. John Finberg of the Department of Pharmacology at the Technion.
A drug called pregabalin has been shown to be an effective and safe treatment for pain in patients with fibromyalgia, according to study data being presented at the annual meeting of the American College of Rheumatology. The drug, Pregabalin, also was shown to improve sleep and fatigue levels, the data demonstrate. Fibromyalgia syndrome (FMS) is a chronic disorder characterized by widespread musculoskeletal pain that is frequently associated with fatigue and sleep disturbances. It is estimated to affect two percent of the population, or 5.6 million Americans, and occurs most frequently in women.